期刊文献+

载10-羟基喜树碱超声微泡的制备、表征及其体外超声成像特性 被引量:4

Preparation,characteristics of imaging and in vitro release of 10-hydroxycamptothecin-loaded microbubbles
下载PDF
导出
摘要 目的 制备载10-羟基喜树碱缓释超声微泡,并考察其体外释药特性和体外超声成像特性.方法 以高分子多聚物聚乳酸为材料,以W/O/W型乳化溶剂挥发法制备载羟基喜树碱超声微泡.结果 扫描电子显微镜观察载10-羟基喜树碱超声微泡具有明显的球状结构;粒度分布在0.45 ~ 5.12 μm之间;采用荧光分光光度法测定其载药量和包封率分别为(4.10±1.29)%和(67.44±2.55)%;体外释放可持续48 h,累积释放率达到60%;此外,体外超声成像显示微泡具有良好的反射超声信号能力.结论 载羟基喜树碱超声微泡可以作为造影剂进行药代动力学的研究. AIM To prepare 10-hydroxycamptothecin (HCPT) -loaded microbubbles, and to determine the profiles of its encapsulation efficiency, in vitro release, and ultrasound imaging. METHODS HCPT-loaded mi- crobubbles was prepared through W/O/W double emulsion technique with polylactic acid (PLA) as the material. RESULTS Laser scanning microscope was for observation of the encapsulation of the microbubbles with particle sizes ranging from 0. 45 μm to 5.12 μm. The encapsulation efficiency and HCPT-loading content were determined by fluorescence spectrophotometry and were measured to be (67.44 ± 2.55 )% and (4. 10 ± 1.29 )% , respective- ly. The in vitro release data showed that total 60% of HCPT was continuously released from the HCPT-loaded mi- crobubbles within forty-eight hours. HCPT-loaded microbubbles also displayed a good ultrasound reflection ability through in vitro ultrasound imaging. CONCLUSION HCPT-loaded microbubbles can be applied as a contrast medium for the pharmacokinetics study.
出处 《中成药》 CAS CSCD 北大核心 2014年第10期2060-2064,共5页 Chinese Traditional Patent Medicine
基金 引进国际先进林业技术项目(2012-4-04) 黑龙江省留学归国基金项目(LC201004)
关键词 10-羟基喜树碱 超声微泡 制备 表征 10-hydroxycamptothecin (HCPT) drug-loaded microbubbles preparation characteristics
  • 相关文献

参考文献12

二级参考文献96

共引文献37

同被引文献43

  • 1段友容,张志荣,唐永刚.PELGE纳米粒的制备及影响粒径大小的因素[J].四川大学学报(医学版),2005,36(1):115-118. 被引量:6
  • 2郑彩虹,梁文权,虞和永.海藻酸壳聚糖聚乳酸羟乙醇酸复合微球的制备及其对蛋白释放的调节[J].药学学报,2005,40(2):182-186. 被引量:20
  • 3袁金芳,郭保林,张晓丽,高青雨.pH、离子强度敏感性壳聚糖水凝胶的合成及其对辅酶A的控制释放[J].功能材料,2007,38(1):36-39. 被引量:3
  • 4Wall ME,Wani MC,Cook CE,et al.Plant antitumor agents.I.The isolation and structure of camptothecin,a novel alka- loidal leukemia and tumor inhibitor from Camptotheca acumi- nata.J Am Chem Soc,1966,88:3888-3890.
  • 5Liehr JG,Harris NJ,Mendoza J,et al.Pharmacology of camp- tothecin esters.Ann NY Acad Sci,2000,922:216-223.
  • 6Zhang R (张瑞).Preparation and characterization of con- trolled-release formulations for methoxycamptothecin nanop- articles.Haerbin:Northeast Forestry University(东北林业大学),PhD.2013.
  • 7Lin LZ(林隆泽),Zhao ZY(赵志远),Xu RS(徐任生).Chemical constituents of the anticancer plant Camptotheca acuminata Decne.化学学报,1977,35;227-231.
  • 8Zheng J (郑健).Pharmacokinetic studies of 10-methoxy- camptothecin in rats.Harbin:Northeast Forestry University(东北林业大学),PhD.:2013,.
  • 9Sanchez A,Tobio M,Gonzalez L,et al.Biodegradable micro- and nanoparticles as long-term delivery vehicles for interfer- on-alpha.Eur J Pharm Sci,2003,18:221-229.
  • 10Murakami H,Kobayashi M,Takeuchi H,et al.Further appli- cation of a modified spontaneous emulsification solvent diffu- sion method to various types of PLGA and PLA polymers for preparation of nanoparticles.Power Technol,2000,107:137-143.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部